Defining the moribund condition as an experimental endpoint for animal research

ILAR Journal

Volumn 41, Issue 2, 2000, Pages 72-79

  Toth, Linda A ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL WELFARE; DEATH; EUTHANASIA; EXPERIMENTAL ANIMAL; LABORATORY; MENTAL STRESS; METHODOLOGY; PAIN; RESEARCH; REVIEW; STRESS;

ANIMAL WELFARE; ANIMALS; ANIMALS, LABORATORY; DEATH; EUTHANASIA; LABORATORY ANIMAL SCIENCE; PAIN; RESEARCH; STRESS; STRESS, PSYCHOLOGICAL;

EID: 0034575036     PISSN: 10842020     EISSN: None     Source Type: Journal    
DOI: 10.1093/ilar.41.2.72     Document Type: Article

References (83)

1. Allard P, Donne A, Potvin D. 1995. Factors associated with length of survival among 1081 terminally ill cancer patients. J Palliat Care 11:20-24.
2. Andrews K, Murphy L, Munday R, Littlewood C. 1996. Misdiagnosis of the vegetative state: Retrospective study in a rehabilitation unit. Br Med J 313:13-16
3. Ashwal S, Cranford R, Bernat JL, Celesia G, Coulter D, Eisenberg H, Myer E, Plum F, Walker M, Watts C, Rogstad T. 1994a. Medical aspects of the persistent vegetative state (first of two parts). N Engl J Med 330:1499-1508.
4. Ashwal S, Cranford R, Bernat JL, Celesia G, Coulter D, Eisenberg H, Myer E, Plum F, Walker M, Watts C, Rogstad T. 1994b. Medical aspects of the persistent vegetative state (second of two parts). N Engl J Med 330:1572-1579.
5. Baker DW, Hays RD, Brook RH. 1997. Understanding changes in health status: Is the floor phenomenon merely the last step of the staircase? Med Care 35:1-15.
6. Barriere SL, Lowry SF. 1995. An overview of mortality risk prediction in sepsis. Crit Care Med 23:376-393.
7. Beresford HR. 1997. The persistent vegetative state: A view across the legal divide. Ann NY Acad Sci 835:386-394.
8. Bergner M, Bobbitt RA, Pollard WE, Martin DP, Gilson BS. 1976. The sickness impact profile: Validation of a health status measure. Med Care 14:57-67.
9. Bernat JL. 1992. The boundaries of the persistent vegetative state. J Clin Ethics 3:176-180.
10. Beynen AC, Baumans V, Bertens APMG, Haas JWM, Van Hellemond KK, Van Herck H, Peters MAW, Stafleu FR, Van Tintelen G. 1988. Assessment of discomfort in rats with hepatomegaly. Lab Anim 22:320-325.
11. Bindman AB, Keane D, Lurie N. 1990. Measuring health changes among severely ill patients: The floor phenomenon. Med Care 28:1142-1152.
12. Childs NL, Mercer WN. 1996. Late improvement in consciousness after post-traumatic vegetative state. N Engl J Med 334:24-25.
13. Clarke R. 1997. Issues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models. Breast Cancer ResTreat 46:255-278.
14. Clemmer TP, Fisher CJ, Bone RC, Slotman GJ, Metz CA, Thomas FO. 1992. Hypothermia in the sepsis syndrome and clinical outcome. Crit Care Med 20:1395-1401.
15. Coyle N, Adelhardt J, Foley KM, Portenoy RK. 1990. Character of terminal illness in the advanced cancer patient: Pain and other symptoms during the last four weeks of life. J Pain Symptom Manage 5:83-93.
16. Dawes RM, Faust D, Meehl PE. 1989. Clinical versus actuarial judgment. Science 243:1668-1674.
17. Debets JMP, Kampmeijer R, van der Linden MPMH, Buurman WA, van der Linden CJ. 1989. Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 17:489-494.
18. Dellinger EP. 1988. Use of scoring systems to assess patients with surgical sepsis. Surg Clin N Am 68:123-145.
19. den Daas N. 1995. Estimating length of survival in end-stage cancer: A review of the literature. J Pain Symptom Manage 10:548-555.
20. de Papp E, Drobatz KJ, Hughes D. 1999. Plasma lactate concentrations as a predictor of gastric necrosis and survival among dogs with gastric dilatation-volvulus: 102 cases (1995-1998). J Am Vet Med Assoc 215:49-52.
21. Deyo RA, Inui TS. 1984. Toward clinical applications of health status measures: Sensitivity of scales to clinically important changes. Health Serv Res 19:275-289.
22. Evans C, McCarthy M. 1985. Prognostic uncertainty in terminal care: Can the Karnovsky index help? Lancet 1:1204-1206.
23. Fitzpatrick R, Ziebland S, Jenkinson C, Mowat A, Mowat A. 1992. Importance of sensitivity to change as a criterion for selecting health status measures. Qual Health Care 1:89-93.
24. Forster LE, Lynn J. 1988. Predicting life span for applicants to inpatient hospice. Arch Intern Med 148:2540-2543.
25. Giacino JT. 1997. Disorders of consciousness: Differential diagnosis and neuropathologic features. Semin Neurol 17:105-111.
26. Girardin E, Grau GE, Dayer JM, Roux-Lombard P, Lambert PH. 1988. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 319:397-400.
27. Goldhill DR, Withington PS. 1996. Mortality predicted by APACHE II: The effect of changes in physiological values and post-ICU hospital mortality. Anaesthesia 51:719-723.
28. Gordon CJ, Fogelson L, Highfill JW. 1990. Hypothermia and hypometabolism: Sensitive indices of whole-body toxicity following exposure to metallic salts in the mouse. J Toxicol Environ Health 29:185-200.
29. Gourmelon P, Briet D, Clarencon D, Court L, Tsiang H. 1991. Sleep alterations in experimental street rabies virus infection occur in the absence of major EEG abnormalities. Brain Res 554:159-165.
30. Gourmelon P, Briet D, Court L, Tsiang H. 1986. Electrophysiological and sleep alterations in experimental mouse rabies. Brain Res 398:128-140.
31. Heyse-Moore LH, Johnson-Bell VE. 1987. Can doctors accurately predict the life expectancy of patients with terminal cancer? Palliat Med 1:165-166.
32. Higginson I, McCarthy M. 1989. Measuring symptoms in terminal cancer: Are pain and dyspnea controlled? J R Soc Med 82:264-267.
33. Huang Y-W, Richardson JA, Tong AW, Zhang B-Q, Stone MJ, Vitetta ES. 1993. Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease. Cancer Res 53:1392-1396.
34. Huang Y-W, Richardson JA, Vitetta ES. 1995. Anti-CD54 (ICAM-1) has antitumor activity in SCID mice with human myeloma cells. Cancer Res 55:610-616.
35. Incalzi RA, Landi F, Pagano F, Capparella O, Gemma A, Carbonin PU. 1998. Changes in nutritional status during the hospital stay: A predictor of long-term survival. Aging Clin Exp Res 10:490-496.
36. Jackson SR, Tweeddale MG, Barnett MJ, Spinelli JJ, Sutherland HJ, Reece DE, Klingemann H-G, Nantel SH, Fung HC, Toze CL, Phillips GL, Shepherd JD. 1998. Admission of bone marrow transplant recipients to the intensive care unit: Outcome, survival and prognostic factors. Bone Marrow Transplant 21:697-704.
37. Janczewski KH, Chalk CL, Pyles RB, Parysek LM, Unger LW, Warnick RE. 1998. A simple, reproducible technique for establishing leptomeningeal tumors in nude rats. J Neurosci Meth 85:45-49.
38. Jones GR. 1998. Assessment criteria in identifying the sick sepsis patient. J Infect 37(Suppl 1):24-29.
39. Khan WA, Dhar U, Salam MA, Griffiths JK, Rand W, Bennish ML. 1999. Central nervous system manifestations of childhood shigellosis: Prevalence, risk factors, and outcome. Pediatrics 103:1-8.
40. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. 1985. APACHE II: A severity of disease classification system. Crit Care Med 13:818-829.
41. Knaus WA, Wagner DP, Lynn J. 1991. Short-term mortality predictions for critically ill hospitalized adults: Science and ethics. Science 254:389-394.
42. Kort WJ, Hekking-Weijma JM, TenKate MT, Sorm V. 1997. A microchip implant system as a method to determine body temperature of terminally ill rats and mice. Lab Anim 32:260-269.
43. Krarup A, Chattopadhyay P, Bhattacharjee AK, Burge JR, Ruble GR. 1999. Evaluation of surrogate markers of inpending death in the galactosamine-sensitized murine model of bacterial endotoxemia. Lab Anim Sci 49:545-550.
44. Krishna S, Waller DW, ter Kuile F, Kwiatkowski D, Crawley J, Craddock CFC, Nosten F, Chapman D, Brewster D, Holloway PA, White NJ. 1994. Lactic acidosis and hypoglycaemia in children with severe malaria: Pathophysiological and prognostic significance. Trans R Soc Trop Med Hyg 88:67-73.
45. Lawrence M. 1995. The unconscious experience. Am J Crit Care 4:227-232.
46. Le Gall J-R, Lemeshow S, Leleu G, Klar J, Huillard J, Rué M, Teres D, Artigas A. 1995. Customized probability models for early severe sepsis in adult intensive care patients. JAMA 273:644-650.
47. Le Gall J-R, Lemeshow S, Saulnier F. 1993. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963.
48. Lemeshow S, Teres D, Pastides H, Avrunin JS, Steingrub JS. 1985. A method for predicting survival and mortality of ICU patients using objectively derived weights. Crit Care Med 13:519-525.
49. Lemeshow S, Teres D, Pastides H, Avrunin JS, Pastides H. 1987. A comparison of methods to predict mortality of intensive care unit patients. Crit Care Med 15:715-722.
50. Louie A, Liu W, Liu Q-F, Sucke AC, Miller DA, Battles.A, Miller MH. 1997. Predictive values of several signs of infection as surrogate markers for mortality in a neutropenic guinea pig model of Pseudomonas aeruginosa sepsis. Lab Anim Sci 47:617-623.
51. Marano MA, Fong Y, Moldawer LL, Wei H, Calvano SE, Tracey KJ, Barie PS, Manogue K, Cerami A, Shires GT, Lowry SF. 1990. Serum cachectin/tumor necrosis factor in critically ill patients with bums correlates with infection and mortality. Surg Gynecol Obstet 170:32-38.
52. Marsh K, Forster D, Wamiru C, Mwangi I, Winstanley M, Marsh V, Newton C, Winstanley P, Warn P, Peshu N, Pasvol G, Snow R. 1995. Indicators of life-threatening malaria in African children. N Engl J Med 332:1399-1404.
53. Martens P, Raabe A, Johnsson P. 1998. Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke 29:2363-2366.
54. McQuillen MP. 1991. Can people who are unconscious or in the "vegetative state" perceive pain? Issues Law Med 6:373-383.
55. Meduri GU, Headley S, Tolley E, Shelby M, Stentz F, Postlethwaite A. 1995. Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS. Chest 108:1315-1325.
56. Mor V, Laliberte L, Morris JN, Wiemann M. 1984. The Kamovsky performance status scale: An examination of its reliability and validity in a research setting. Cancer 53:2002-2007.
57. Morrow NS, Schall M, Grijalva CV, Geiselman PJ, Garrick T, Nuccion S, Novin D. 1997. Body temperature and wheel running predict survival times in rats exposed to activity-stress. Physiol Behav 62:815-825.
58. Morton DB, Griffiths PHM. 1985. Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. Vet Rec 116:431-436.
59. Olfert ED. 1996. Considerations for defining an acceptable endpoint in lexicological experiments. Lab Anim 25:38-43.
60. Parkes CM. 1972. Accuracy of predictions of survival in later stages of cancer. Br Med J 2:29-31.
61. Phu NH, Day N, Diep PT, Ferguson DJP, White NJ. 1995. Intraleucocytic malaria pigment and prognosis in severe malaria. Trans R Soc Trop Med Hyg 89:200-204.
62. Plum F, Schiff N, Ribary U, Llinás R. 1998. Coordinated expression in chronically unconscious persons. Philos Trans R Soc Lond 353:1929-1933.
63. Prytherch DR, Whiteley MS, Higgins B, Weaver PC, Prout WG, Powell SJ. 1998. POSSUM and Portsmouth POSSUM for predicting mortality. Br J Surg 85:1217-1220.
64. Rechtschaffen A, Gilliland MA, Bergmann BM, Winter JB. 1983. Physiological correlates of prolonged sleep deprivation in rats. Science 221:182-184.
65. Redgate ES, Deutsch M, Boggs SS. 1991. Time of death of CNS tumorbearing rats can be reliably predicted by body weight-loss patterns. Lab Anim Sci 41:269-273.
66. Reuben DB, Mor V. 1986. Dyspnea in terminally ill cancer patients. Chest 89:234-236.
67. Reuben DB, Mor V, Hiris J. 1988. Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 148:1586-1591.
68. Schiff ND. 1999. Commentary: Neurobiology, suffering, and unconscious brain states. J Pain Symptom Manage 17:303-304.
69. Schnaper N. 1975. The psychological implications of severe trauma: Emotional sequelae to unconsciousness. J Trauma 15:94-98.
70. Seneff M, Knaus WA. 1990. Predicting patient outcome from intensive care: A guide to APACHE, MPM, SAPS, PRISM, and other prognostic scoring systems. J Intensive Care Med 5:33-52.
71. 50 for measurement of bacterial virulence. Int J Exp Path 73:95-98.
72. Stiles BG, Campbell YG, Castle RM, Grove SA. 1999. Correlation of temperature and toxicity in murine studies of staphylococcal enterotoxins and toxic shock syndrome toxin 1. Infect Immun 67:1521-1525.
73. Tosch P. 1988. Patients' recollections of their posltraumatic coma. J Neurosci Nurs 20:223-228.
74. Toth LA. 1997. The moribund state as an experimental endpoint. Contemp Top Lab Anim Sci 36:44-48.
75. Toth LA, Rehg JE, Webster RG. 1995. Strain differences in sleep and other pathophysiological sequelae of influenza virus infection in naive and immunized mice. J Neuroimmunol 58:89-99.
76. Toth LA, Tolley EA, Krueger JM. 1993. Sleep as a prognostic indicator during infectious disease in rabbits. Proc Soc Exp Biol Med 203:179-192.
77. Tunnell RD, Millar BW, Smith GB. 1998. The effect of lead time bias on severity of illness scoring, mortality prediction and standardised mortality ratio in intensive care-A pilot study. Anaesthesia 53:1045-1053.
78. Ventafridda V, Ripamonti C, De Conno F, Tamburini M. 1990. Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 6:7-11.
79. Waller D, Krishna S, Crawley J, Miller K, Nosten F, Chapman D, ter Kuile FO, Craddock C, Berry C, Holloway PAH, Brewster D, Greenwood BM, White NJ. 1996. Clinical features and outcome of severe malaria in Gambian children. Clin Infect Dis 21:577-587.
80. Welsh DK, Richardson GS, Dement WC. 1986. Effect of age on the circadian pattern of sleep and wakefulness in the mouse. J Gerontol 41:579-586.
81. Wong M-L, Bongiomo PB, Rettori V, McCann SM, Licinio J. 1997. Interleukin (IL) Iß, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: Pathophysiological implications. Proc Natl Acad Sci U S A 94:227-232.
82. Yates JW, Chalmers B, McKegney P. 1980. Evaluation of patients with advanced cancer using the Karnovsky performance status. Cancer 45:2220-2224.
83. Zandbergen EGJ, de Haan RJ, Stoutenbeek CP, Koelman JHTM, Hikdra A. 1998. Systematic review of early prediction of poor outcome in anoxicischaemic coma. Lancet 352:1808-1812.